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Abstract
Background: Initiation of the hair follicle placode and its subsequent growth, maturation and cycling in post-natal
skin requires signaling interactions between epithelial cells and adjacent dermal cells and involves Shh signaling via
the primary cilium. Previous reports have implicated laminins in hair follicle epithelial invagination.
Results: Here we use a human BCC model system and mouse mutants to re-evaluate the role of laminin-511 in
epithelial invagination in the skin. Blocking laminin 511 and 332 in BCCs maintains primary cilia and Shh signalling,
but prevents invagination. Similarly, in laminin-511 and dermal beta-1 integrin mutants, dermal papilla
development and primary cilia formation are normal. Dermal beta-1 integrin mutants have normal hair follicle
development.
Conclusions: Our data provides support for a primary role of laminin-511 promoting hair follicle epithelial
downgrowth without affecting dermal primary cilia and Shh target gene induction.
Background
Hair follicle morphogenesis requires signaling interac-
tions between epithelial cells and adjacent dermal cells
that form the specialized mesenchyme called the dermal
papilla. During these processes, Sonic hedgehog (Shh)
signaling is required in both the epithelial and dermal
compartments. Inappropriate epithelial Shh target gene
induction is sufficient to cause basal cell carcinoma
(BCC), one of the most common tumors in Caucasians,
with an incidence of over a million cases per year in the
U.S. BCCs also have a striking reliance on adjacent
stroma for continued growth and invasion, implying
that non-cell autonomous factors influence the extent of
Shh target gene induction in tumors [1-3]. Despite
extensive study, factors that regulate epithelial-mesench-
ymal interactions during normal or neoplastic epithelial
growth remain poorly understood.
The primary cilium is a microtubule-based organelle
crucial for the regulation of Shh signalling and growth
(for reviews see [4-7]). Receptors positioned within the
cilium transduce signals through transcription factors
that are activated directly in the cilium or in the cell
body. Mutations giving rise to defective primary cilia or
improper placement of signaling molecules within the
cilium result in a plethora of clinical manifestations
[8,9]. In particular, mutations in genes encoding intrafla-
gellar transport proteins impair Shh signaling and result
in limb bud and neural tube defects similar to those
seen with inactivating mutations of the Shh pathway
[10-14]. Two recent reports describe requirements for
IFT88, an intraflagellar transport component, and Miss-
ing in Metastasis, an actin regulatory protein, for Shh
signalling in the dermal papilla and depict a necessary
role for the primary cilia in hair follicle development
[15,16]. Moreover, a requirement for the primary cilia in
BCC formation has been demonstrated, which reinforces
the importance of the primary cilia in Shh signaling and
epithelial downgrowth [17].
Laminin-511, a basement membrane zone protein, is
also required for hair follicle downgrowth. Laminin-511
(LM511) and laminin-332 (LM332) are the most abun-
dant laminins in developing and adult skin. Both are
secreted from keratinocytes and incorporate into the
basement membrane zone of hair follicles and interfolli-
cular epithelia, but LM511 is particularly abundant in
the basement membrane zone surrounding hair follicles
(for a review see [18]). Laminins also signal intracellu-
larly through transmembrane receptors, including the
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the most abundant LM511 receptor pair is integrin
alpha-3, beta-1. LM332, on the other hand, predomi-
nantly associates with integrin alpha-6, beta-4 in hemi-
desmosomes [19]. These interactions have only been
described, however, for integrin receptors within epithe-
lial cells, not dermal papilla cells.
Mice null for the alpha 5 subunit of LM511 (lama5-/-
mice) show arrest of hair follicles during the hair germ
stage of hair follicle morphogenesis. Arrested follicles
resemble SHH-null follicles, indicate reduced expression
of SHH and GLI1 in hair follicle epithelia and have a
r e d u c t i o ni ne p i t h e l i a lp r o l i f e r a t i o n[ 2 0 ] .F u r t h e r m o r e ,
previous results indicated that primary cilia are absent
in the dermal papilla of lama5-/- mice at E16.5 [21].
These and additional observations suggested that epithe-
lial derived LM511, through binding integrin beta-1
(Itb1), maintains the primary cilia in dermal papilla cells
and is therefore required for Shh ligand reception in
those cells.
In contrast, epithelial-derived laminins are also known
to act directly on the epithelium to promote invasion.
Developmental studies with conditional mutants of
epithelial Itb1 demonstrate its role in epidermal/dermal
attachment and proper hair follicle development [22,23].
In human graft models of SCC, epithelial downgrowth
depends on both Itb1 and LM332, which indicates a
need for both adheshion and signaling for continued
epithelial growth [24].
Here we use a human BCC model system and a con-
ditional mouse mutant lacking Itb1 in dermal mesench-
yme to re-evaluate the role of LM511 in epithelial
downgrowth. We provide evidence that LM511 interac-
tion with integrin b1 in epithelium, rather than with
dermal papilla, is required for hair follicle invagination.
Results
LM511 and LM332 blockade inhibits BCC invasion but not
Shh signaling
Human skin xenografts overexpressing Shh ligand pro-
vide an excellent model to study in vivo BCC lesion for-
mation [25]. We used antibody blocking reagents in
conjunction with this model to determine whether lami-
nin function is required for BCC formation in these
grafts. The 4c7 antibody binds the LM511 globular
domain and thereby inhibits integrin binding [26]. The
BM165 antibody was raised against the a3s u b u n i to f
LM332 [27]. For experiments receiving a single antibody
(IgG, 4c7 or BM165) animals received intraperitoneal
injections carrying 1.0 mg of antibody starting in the
first week of growth and then every week thereafter. In
a preliminary experiment, we determined that blocking
grafts with both LM511 and LM332 antibodies in the
first week of growth results in severe blistering, so in
this case we began injections in the second week of
growth. Some grafts, especially those treated with
BM165 to block LM332 function (starting in the first
week of grafting), were lost due to the formation of scar
tissue in the graft site [28].
SHH/IgG grafts form BCC-like lesions as expected
(n = 3) and contain thickened epidermis and invagina-
tions with hallmark BCC features including pallisading
basal cells and the strong presence of dermal cells at the
epidermal/dermal boundary (Figure 1A). This contrasts
sharply with the thin, orderly skin present in GFP/IgG
control grafts (n = 4). We confirmed that all grafts ana-
lyzed contain human skin, and not murine host skin,
using species-specific human involucrin antibodies
(Figure 1B). We also determined that graft tissues incor-
porate both human LM511 and human LM332 into the
basement membrane zone, exclude mouse LM511 and
are targeted by injected blocking antibodies (data not
shown). Severe invaginations similar in appearance to
those in SHH/IgG grafts are also evident in all SHH/4c7
grafts (n = 4), indicating that LM511 blockade does not
reduce Shh-mediated BCC formation (Figure 1A). On
the other hand, blocking both LM511 and LM332 func-
tion (n = 4) inhibits the BCC epithelial invagination
seen in Shh/IgG grafts. In each of the double-blocked
grafts, stratified epithelium was present with little if any
epithelium progressing past the dermal/epidermal
boundary.
Lack of BCC epithelial invasion could be caused by
lack of Shh responsiveness or Shh-dependent invasive-
ness, so we next assessed the Shh target gene induction
in double-blocked grafts. As expected, GFP expressing
tissues display only a single layer of keratin 10-negative
(basal) cells (Figure 1C) whereas those of SHH/IgG and
SHH/4c7 grafts demonstrate extensive basal layer prolif-
eration and invagination. Notably, the epithelium of
SHH/4c7, BM165 grafts exhibit 2-3 layers of keratin-10
negative cells similar to the keratin-10 expression profile
of non-invasive regions of SHH/IgG and SHH/4c7 grafts.
These grafts show additional basal layer proliferation
and indicate persistent Shh response in LM511/LM332
blocked tissues.
To probe this issue further, we determined the expres-
sion of Shh target genes as well as indicators of epithe-
lial cell proliferation and apoptosis. To determine the
extent of Shh target gene induction in the grafts, we
performed RNA in-situ hybridization with DIG-labeled
RNA probes for PTCH1, a direct target of Shh pathway
activation. Anti-sense probes for PTCH1 show the pre-
sence of Shh target gene expression, concentrated in
basal cells at the leading edge of epithelial invaginations,
in SHH/IgG and SHH/4c7 grafts (Figure 1D, arrows).
Despite the reduced appearance of invaginations in
SHH/4c7, BM165 grafts, these grafts contain PTCH1
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Page 3 of 15Figure 1 LM511 and LM332 inhibition reduces tumor invasion in human BCC skin xenografts. A: Hematoxylin and eosin-stained sections
of human skin xenografts carrying either control GFP or SHH retrovirus and treated with control IgG, 4c7 antibody against LM511 or BM165
antibody against LM332, as indicated. Images captured at 20x magnification. B: Indirect immunofluoresence for human-specific involucrin (red)
confirms the human origin of graft tissue. C: Indirect immunofluoresence for keratin 10 (green) indicates all non-basal cells in graft epidermis.
D: DIG RNA in-situ with anti-sense probe to PTCH1 transcript in indicated xenografts. Anti-sense probe signal is seen in all SHH-expressing grafts.
Black dotted lines indicate epidermal/dermal boundary. Red arrows indicate DIG signal. D’: DIG RNA in-situ with sense probe to PTCH1 transcript
in indicated xenografts. Images are 20x magnification. E: Indirect immunofluoresence for Ki67 (red) in indicated graft tissues marks proliferating
cells. F: TUNEL-TMR Red staining indicates apoptotic cells in graft tissues. E-F: White dashed lines indicate the epidermal/dermal boundary. Scale
bars indicate 100 μm.
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Page 4 of 15transcript concentrated in the basal half of the epider-
mis. The expression of these genes is specific, as
GFP-expressing xenografts do not show detectable levels
of these transcripts. In addition, control sense probes
corresponding to the PTCH1 transcript do not provide
signal in all grafts (Figure 1D’). We conclude, then, that
the lack of epithelial invagination in SHH/4c7, BM165
grafts is not due to an inability of the Shh pathway to
activate target genes.
Shh signaling has a variety of effects on responding
cells in a tumorigenic context, but its most notable
effects are an increase in proliferation and inhibition of
apoptosis in responsive cells. If laminin blockade
reduces Shh target gene induction, it may affect the
proliferation or apoptotic index of responsive tissues.
Therefore, we determined the extent of proliferation
and apoptosis in xenograft lesions. We assessed the
extent of proliferation in xenografts with immuno-
fluoresence for Ki67, a marker of cellular proliferation.
GFP/IgG grafts contain a limited number of proliferat-
ing basal cells, restricted to a single cell layer, in the
epidermis (Figure 1E). GFP/4c7, BM165 grafts likewise
contain few proliferating basal cells. As expected.
SHH/IgG and SHH/4c7 grafts contain an abundance of
proliferating cells within tumor invaginations. Concor-
dant with the histological phenotype, SHH/4c7, BM165
grafts contain fewer proliferating cells than SHH/IgG
or SHH/4c7 grafts. However, these tissues contain
more proliferating cells than the control GFP/4c7,
BM165 grafts and even contain proliferating cells in
suprabasal layers of the epidermis, which mirrors the
proliferation profile of non-invasive regions of SHH/
IgG and SHH/4c7 tissues (Figure 1E and Additional
File 1, Figure S1). This indicates that blockade of
LM511 and LM332 in SHH-expressing grafts does not
affect the increased proliferation of cells experiencing
excess SHH ligand.
In order to determine the apoptotic index in graft tis-
sues, we utilized a fluorescent TUNEL assay. If laminin
blockade affects Shh survival signals, we would expect
to see an increase in the number of apoptotic nuclei in
antibody-treated grafts. This is not the case, as all
grafts only show apoptotic nuclei within the stratified
layers of the epidermis, not in the relevant basal layer
(Figure 2F). We conclude, then, that blockade of LM511
and LM332 in human skin xenografts also does not
abolish any anti-apoptotic effects mediated by Shh sig-
nalling in epithelial cells.
Our results regarding Shh target gene expression, pro-
liferation and apoptosis in xenograft tissues indicate that
antibody blockade of LM511 and LM332 does not dras-
tically reduce Shh response of relevant cells in a tumori-
genic context. Since LM511 has been suggested to affect
Shh target gene induction in the developing hair follicle
via maintenance of the structure of the primary cilium,
we also investigated the presence of this structure in
our graft experiments.
Human skin xenografts contain epithelial and dermal
primary cilia
Using antibodies to adenyl cyclase III for cilia shaft and
rootletin for the basal body, we were able to visualize
primary cilia in epithelial cells of all human skin
xenografts (Figure 2A and 2B). Furthermore, in SHH-
expressing grafts, we can also visualize primary cilia in
dermal cells adjacent to the basement membrane zone
(Figure 2C). Combinatorial staining for keratin 10,
which localizes to all suprabasal cells, indicates that the
presence of the primary cilia in a cell negatively corre-
lates with keratin 10 expression. Invasions within SHH/
IgG or SHH/4c7 grafts have a greater ratio of keratin
10-negative (basal) epithelial cells to all epithelial cells
(Figure 1C), and likewise indicate a large number of
cells with primary cilia. Grafts expressing control virus
contain only a single layer of keratin 10-negative/cilia-
positive cells and exhibit primary cilia only in these
cells. Accordingly, non-invasive regions of SHH/IgG and
SHH/4c7 and all regions of SHH/4c7, BM165 grafts
have 2-3 layers of primary cilia-containing basal cells
(Figure 2D and data not shown). So, we can conclude
that blocking LM511 alone or blocking both LM511 and
LM332 does not ablate primary cilia in epithelial cells
or dermal cells adjacent to the basement membrane
zone in our xenograft model. We, therefore, also con-
clude that any negative effect that LM511 and LM332
inhibition has on tumor invasiveness is primary cilia-
independent.
Dermal papilla in hair follicles of lama5-/- mice appear
normal at E16.5
The absence of effects of laminin blockade on primary
cilia formation and Shh responsiveness in human skin
xenografts lead us to revisit the previously established
relationship between LM511, primary cilia and Shh
responsiveness in developing murine hair follicles. In
particular, we examined whether lama5-/- mice have
discernible differences in known early dermal papilla
markers compared to wild type mice. We first con-
firmed that lama5-/- mice lack LM511 incorporation in
the basement membrane zone. The antigen is apparent
around hair follicles of control and absent from those in
null mice (Figure 3A). We next compared the expres-
sion of several markers of developing dermal papilla in
E16.5 mice [29-33]. For the early dermal papilla markers
CD133, p75 and syndecan-1, we find similar expression
in dermal condensates associated with Stage 1 and Stage
2 hair follicles in control and lama5-/- animals
(Figure 3C-E). In addition, we also quantified the
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these mice and obtain similar results for Stage 1 and
Stage 2 follicles in control and null animals. Our analy-
sis, then, fails to show any abnormalities in the dermal
papilla of lama5-/- mice at E16.5.
Similarly, we examined the presence of primary cilia in
dermal papilla of E16.5 lama5-/- mutants. We find that
mutant mice do contain primary cilia in dermal conden-
sates of developing hair follicles (Figure 4A-D). At
E14.5, we observe primary cilia in dermal cells adjacent
Figure 2 Xenograft tissues contain primary cilia. A-C: Indirect immunofluoresence for cilia components. Adenylyl cyclase III (green) indicates
cilia shafts, rootletin (red) indicates the basal body at the base of the cilia and Hoechst dye (blue) indicates cell nuclei. A: Cilia are present in
both epithelial and dermal cells. B: Zoom of epithelial cells in A. C: Zoom of dermal cells in A. D: Indirect immunofluoresence for cilia
components and suprabasal cells. A cyclase III (green) and rootletin (red) mark cilia. Keratin10 (blue) marks suprabasal cells. Hoechst dye (white)
indicates cell nuclei. Robust cilia are present only in cells excluding keratin 10. D’: Zoom of boxed areas in D. All dashed lines indicate epidermal/
dermal boundaries.
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Page 6 of 15Figure 3 Laminin alpha 5 null hair follicles normally express dermal papilla markers. A: Images of indirect immunofluoresence for mouse
LM511 (green) in E16.5 wild type and lama5-/- mice (as indicated) showing a lack of antigen in null animals A’: The same images as (A)
indicating the Stage 2 hair follicles present in each view. B: Quantitation of p75-positive cells in dermal condensate of Stage 1 and Stage 2 hair
follicles of E16.5 wild type and lama5-/- mice. C-E: Confocal images of indirect immunofluoresence for dermal markers CD133 (C), p75 (D) and
syndecan-1 (E) in wild type and lama5-/- Stage 1 and Stage 2 follicles within E16.5 skin. Hoechst (blue) labels cell nuclei. Dashed lines indicate
epidermal/dermal boundary of hair follicles. Scale bars represent 10 μm. Abbreviations: DP, dermal papilla; HF, hair follicle.
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Page 7 of 15Figure 4 Hair follicles in laminin alpha 5 null mice have primary cilia. A-D: Confocal z-stacks of primary cilia and dermal papilla in hair
follicles of E14.5 (A-B) and E16.5 (C-D) skin of wild type (A, C) and lama5-/- (B, D) animals. Adenylyl cyclase III (green) indicates the primary cilia,
CD133 (red) marks the dermal papilla cells and Hoechst dye (blue) indicates cell nuclei. A’-D’: Zoom of boxed areas in A-D. E: Confocal z-stacks of
primary cilia in dermal papilla of wild type E16.5 skin treated overnight with either control IgM or Ha2/5 antibody to Itb1 (as indicated).
Immunofluoresence same as in A-D. F: H&E stained frozen sections of 9-day allografts of wild type E16.5 skin treated overnight with either
control IgM or Ha2/5 antibody (as indicated). IgM treated allografts show significant hair growth and normal hair-free skin. Ha2/5 treated
allografts show both blistered and intact epidermis with little to no hair growth, indicating the ability of this antibody to block Itb1 function and
hair follicle development. G: Percent dermal papilla cells with primary cilia in z-stacks of dermal papilla from E16.5 skin treated with either IgM or
Ha2/5 antibody (as in E). All scale bars indicate 10 μm. Abbreviations: DPC, dermal papilla cells; PC, primary cilia; Ab, antibody.
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thickening (Figure 4A-B). At E16.5, we identify the der-
mal papilla in Stage 2 follicles with CD133 and observe
primary cilia in these cells (Figure 4C-D). The number
of dermal papilla cells containing primary cilia was
quantified in wild type and lama5-/- mice at E16.5 and
no significant difference was detected (Figure 4E). In
addition, both wild type and null animals display cilia at
1.5-2.0 μm in length (Figure 4F). We conclude that in
the absence of LM511 protein, dermal papilla differen-
tiation and primary cilia formation proceed normally up
to E16.5.
Epithelial, but not dermal, Itb1 is required for hair follicle
epithelial invasion
A drawback of studies with lama5-/- mutants is that
LM511 is a secreted molecule that can associate with
both epithelial and dermal cells, preventing definite con-
clusions as to the cell type in which it is required.
Consequently we investigated the cell-autonomous
requirement for the LM511 receptor, Itb1, in dermal
cells using both blocking antibodies and mouse mutants.
Initially, we confirmed thee f f e c t i v e n e s so ft h eI t b1
blocking antibody, Ha2/5 [34]. We soaked E16.5 wild
type skin with control IgM and Ha2/5 antibody over-
night and then grafted the treated skin onto the back of
immuno-compromised (SCID) mice for continued
growth. Grafted skin treated with control antibody
formed stable stratified epithelia and regions of dense
hair (Figure 4G, top panels). On the other hand, grafted
skin first treated with Ha2/5 antibody to Itb1f o r m e d
only a minimal patch of graft-derived hair (consisting of
fewer than 10 hair follicles, data not shown) and some
attached stratified epithelia. In large part, these treated
grafts resulted in blistered graft skin, indicating that
blocking Itb1 function in the epithelial cells reduced the
ability of the epidermis to remain associated with the
basement membrane and form hair, which is in line
with previous reports of epithelial Itb1f u n c t i o ni ns k i n
(Figure 4G, lower panels) [22,23].
With this antibody capable of blocking Itb1f u n c t i o n
in murine skin, we treated wild type E16.5 whole back-
skin with Itb1 blocking antibodies overnight, an experi-
ment previously reported to eliminate primary cilia in
dermal papilla cells [21]. Here, treated skin still contains
primary cilia in both epidermal and dermal components
of developing hair follicles (Figure 4I). In these tissues,
both control treated and Ha2/5 antibody treated skin
displayed approximately 65% of dermal papilla cells with
primary cilia (Figure 4H). This result was consistent
when a range of concentrations of blocking antibody
was used, from 40 to 300 μg/ml (data not shown). This
indicates that the Ha2/5 antibody is effective in blocking
Itb1 function, but does not reduce primary cilia in wild
type skin. This corroborates our observation of the pre-
sence of primary cilia in the dermal papilla of lama5-/-
mice and argues against a role for LM511/Itb1i n
ciliogenesis.
To confirm our results with blocking antibodies, we
examined skin function in a mouse lacking Itb1i nt h e
mesenchyme cells of the ventral and lateral skin. Mice
expressing Prx-1 driven Cre-recombinase have been pre-
viously used to demonstrate a requirement for primary
cilia components in hair follicle [15,35]. Thus, we reason
that if LM511 association with Itb1 is required in der-
mal cells for primary cilia formation/maintenance or
proper Shh signaling, conditional deletion of Itb1 in this
cell population should also negatively affect hair follicle
morphogenesis.
Indirect immunofluorescence for Itb1 in ventral/lateral
skin of P1 Prx1-Cre; Itb1
flox/flox mice indicates that these
late stage hair follicles do not express Itb1i nd e r m a l
papilla cells (for a reference to Itb1 antibody staining in
mouse skin see [22]). In control mice, immunofluores-
cence for Itb1 shows cell surface expression of Itb1o n
basal keratinocytes, hair follicle epithelial cells and der-
mal papilla cells (Figure 5G, top panels and Additional
File 2, Figure S2). This expression pattern partially over-
laps with that of p75 which is found on the cell surface
of dermal papilla, suprabasal keratinocytes and in hair
follicle epithelial cells in these late-stage follicles. On the
other hand, ventral hair follicles in conditional knock-
outs contain p75-positive dermal papilla cells void of
Itb1 expression (Figure 5G, bottom panels). In skin of
these mice, Itb1 expression still overlaps with p75
expression in hair follicle epithelial cells (Additional File
2, Figure S2). We also demonstrate that conditional
deletion of dermal Itb1 does not disrupt localization of
LM511. As in control skin, LM511 is observed in der-
mal Itb1 knockouts incorporated into the basement
membrane zone of interfollicular epidermis and hair fol-
licles and is especially pronounced in the basement
membrane zone surrounding follicles (Figure 5H). This
indicates that conditional deletion of dermal Itb1d o e s
not disrupt the localization of LM511 in developing hair
follicles and that the formation of the basement mem-
brane zone is not driven by dermal Itb1b u tb ye p i d e r -
mal Itb1 only [22,23]. We additionally confirmed that
deleting Itb1 from dermal cells does not disrupt addi-
tional components of the basement membrane zone or
extracellular matrix around endothelial structures.
Immunolocalization of tenascin C, fibronectin, perlecan,
collagen I and collagen IV are all comparable in P1 skin
of control and conditional knockouts (Additional File 3,
Figure S3A-E).
At post-natal day 1 (P1), Prx1-Cre; Itb1
flox/flox mice
look relatively normal except for reddened skin in the
areas of expected Prx1-Cre expression (Figure 5A, [35]).
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Page 9 of 15Figure 5 Prx1-Cre; Itb1
flox/flox mice exhibit normal hair follicle morphogenesis and post-natal cycling. A: Mixed littermates (Ctrl) and Prx1-
cre; Itb1
flox/flox (Itb1 KO) mice at 1 day post-natal (P1). Conditional knockouts display slightly reduced size and a reddened appearance on ventral
and lateral surfaces. B: Representative H&E stained skin sections from the ventral skin over the sternum of P1 control and conditional knockout
mice. C: Control and conditional knockout mice at 5 days post-natal (P5) showing the reduced size and reddened ventral skin of mutant mice.
D: H&E stained skin sections from the ventral skin of P5 control and conditional knockout mice showing hair follicles in advanced stages. E:
Quantitation of hair follicle stages in P1 and P5 control and conditional knockout mice showing similar patterns of hair development. F: Control
and conditional knockout mice at 82 days showing the normal appearance of coat on the ventral and lateral regions. G: Immunofluoresence for
p75 (green) and Itb1 (red) in sections of ventral skin from P1 control and conditional knockout mice at P1 (as indicated). Brackets indicate p75+
dermal papilla. Note lack of Itb1 signal in the dermal papilla of a Stage 4 hair follicle (arrow). H: Immunofluoresence for mouse LM511 (green)
shows normal incorporation of this laminin in P1 control and conditional knockout mice. Scale bars represent 20 μm. Abbreviations: Ctrl, control;
Itb1 KO, dermal Itb1 knockout; HFs, hair follilces.
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appearance, as histology does not indicate inflammation
in the skin of these mice (Figure 5B). Histological exam-
ination of ventral skin above the sternum in conditional
knockouts reveals hair follicles in stages varying from
placode to Stage 2 peg (Figure 5B). Analogously, P5
mice maintain the reddened appearance and small size
of P1 mice. Like control mice, the ventral skin of condi-
tional knockout mice at P5 contains abundant fully
developed hair follicles. Quantification of the stages of
hair follicles in P1 and P5, control and knockout
mice indicates comparable developmental patterns
(Figure 5E). Post-natal hair cycling is also normal in
knockout mice, as adult mutants have normal hair coats
in knockout regions (Figure 5F).
In order to confirm that deletion of dermal Itb1d o e s
not have discernable effects on skin development, we
determined the expression of epithelial differentiation
markers loricrin and keratin-10 in skin of conditional
knockouts. Loricrin expression is found in the stratum
granulosum of properly differentiated epidermis. This
expression pattern is evident in control and Prx1-Cre;
Itb1
flox/flox skin (Figure 6A). Similarly, conditional
knock-outs display a normal expression pattern of kera-
tin-10, which localizes to the stratum spinosum and
granulosum of the epidermis (Figure 6B). Deletion of
epithelial Itb1 causes reduced presence of integrin
alpha-6 and integrin beta-4 in associated basement
membrane zone [22]. This is not the case in Prx1-Cre;
Itb1
flox/flox mice as the expression of these integrins is
not altered in basolateral membranes of basal keratino-
cytes (Figure 6B-C). As in lama5-/- mice, dermal papilla
markers appear normal in hair follicles of Prx1-Cre;
Itb1
flox/flox mice. We tested expression of p75 and syn-
decan-1 in conditional knockouts and find expression
domains and levels similar to those in control mice
(Figure 6D and data not shown). We also determine
that the number of p75-positive dermal papilla cells per
hair follicle in dermal Itb1 knockouts is comparable to
that in control mice at P1 in both Stage 1 and Stage 2
hair follicles (Figure 6E). In addition, we confirmed the
presence of primary cilia in dermal papilla of hair folli-
cles in Prx1-Cre; Itb1
flox/flox skin (Figure 6F). We quan-
tified the presence of primary cilia in Stage 1 and Stage
2 hair follicles at this time point and find no difference
in the presence of cilia in control versus conditional
knockout animals (Figure 6G). This indicates that der-
mal Itb1 is not required for the formation of primary
cilia in dermal cells or the condensation of dermal cells
into dermal papilla. Therefore, unlike deletion of Itb1i n
epithelial cells, which has been shown to be necessary
for proper skin and hair formation, deletion of Itb1
from dermal cells does not impact this tissue.
Discussion
In developing skin, laminins have been reported to act via
their integrin receptors on both the epithelium as well as
the underlying dermal organizer. Using a human model
of skin epithelium, we have shown that inhibition of
laminin-511 and 332 function prevents epithelial invagi-
nation, but leaves the primary cilia and Shh target gene
induction apparently intact. Consistent with a primary
effect on the epithelium, few abnormalities derive from
removing the laminin receptor Itb1 in dermal cells, thus
clarifying how laminin-511 functions in the skin.
LM511 and LM332 in primary cilium and Shh signaling
The primary cilium has quickly garnered attention as a
sensory organelle required for correct processing of Shh
signal reception during hair follicle development and
tumorigenesis. A previous model suggested that the
structure of the primary cilia in the dermal papilla
dependended on extracellular cues from the basement
membrane zone through LM511 binding to dermal Itb1
[21]. Our current work, however, argues against a direct
role for laminins 511 or 332 in ciliogenesis or Shh target
gene induction. These differences may be, in part, due
to a previous lack of precise aging of embryonic mice,
which may have resulted in the inadvertent study of
degenerating hair follicles and skin after the mutant ani-
mals began to be reabsorbed in utero. In addition, the
use of mouse anti-human acetylated tubulin antibody to
detect cilia, which is sub-optimal in mouse skin due to
extensive background staining of anti-mouse secondary
antibodies, may have exacerbated these problems. These
are difficulties we believe we have overcome through
careful mouse breeding and the optimization of primary
cilia staining protocols. We believe our conclusions
regarding the lack of a role for LM511 and Itb1i nt h e
dermal papilla are accurate because of the technique
optimization, and the corroboration of our results from
analysis of the dermal Itb1 mutants. Recent studies from
our lab and others have shown the important role of
actin and the microtubule cytoskeleton in maintaining
cilium structure [16,36,37]. However, our current results
reiterate the paucity of information known about cilio-
genesis and the extracellular cues that regulate cilium
function.
In our human BCC xenograft model, blocking both
LM511 and LM332 is required to inhibit tumor inva-
sion, while blocking of LM511 alone has no discern-
able effect. These results sharply contrast with the
inhibition of LM511 in human hair follicle xenografts,
which dramatically inhibits hair follicle epithelial inva-
sion using comparable doses of blocking antibody in a
similar experimental setting [20]. We have thus uncov-
ered a potentially important difference between hair
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Page 11 of 15follicle and BCC epithelial growth. In invaginating hair
follicle epithelium, LM511 is the predominant laminin
supporting hair follicle growth, while in BCCs LM332
appears to be sufficient to compensate for loss
of LM511. Interestingly, recent functional studies
reinforce the differences between hair follicle and BCC
epithelium. Forced activation of the Shh pathway in
interfollicular epithelium, but not hair follicle epithe-
lium induces BCC, suggesting that coexpression
of LM511 and LM332 seen in the interfollicular
Figure 6 Dermal condensates in Prx1-Cre; Itb1
flox/flox mice appear normal and contain primary cilia. A: Immunofluoresence for loricrin
(green) in P1 control and conditional knockout mice, showing similar staining of the statrum granulosum. B: Immunofluoresence for keratin 10
(green) in P1 control and conditional knockout mce, showing similar staining of the straturm spinosum Ita6 staining in A-B shows normal basal
cell layers. C: Immunofluoresence for Itb4 (red) and p75 (green), showing normal levels of Itb4 staining in the epithlelia. D: Immunofluoresence
for p75 (green) in P1 control and Prx1-Cre; Itb1
flox/flox mice showing similar dermal papilla expression patterns. A-D: Scale bars indicate 20 μm.
E: Number of dermal papilla cells in condensates of Stage 1 and 2 hair follicles of P1 control and Prx1-Cre; Itb1
flox/flox mice. F: Confocal z-stacks
of immunofluoresence for primary cilia and dermal papilla in Stage 1 (top panels) and Stage 2 (bottom panels) hair follicles of P1 control and
Prx1-Cre; Itb1
flox/flox mice. Adenylyl cyclase III (green) marks the primary cilium shaft, syndecan I (red) indicates dermal papilla cells and Hoechst
dye (blue) indicates cell nuclei. Scale bars indicate 10 μm. G: Percent dermal papilla cells with a primary cilium in Stage 1 and 2 hair follicles of
P1 control and conditional knockout mice. All dotted lines indicate the epidermal/dermal border. Abbreviations: Ctrl, control; Itb1 KO, dermal Itb1
knockout; DP, dermal papilla; HF, hair follicle.
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Page 12 of 15epithelium may offer a selective advantage for invading
tumors [38].
LM511 and Itb1 in hair follicle morphogenesis
The presence of normal late stage hair follicles in Prx1-
Cre; Itb1
flox/flox mice indicates that dermal Itb1 signaling
is not required for proper hair follicle morphogenesis.
Conditional knockout of epithelial Itb1, on the other
hand, clearly constitutes a requirement for epithelial
Itb1 in skin and hair development [22,23]. This may be
partially due to the role of Itb1i nt h ef o r m a t i o no f
a stable basement membrane zone. LM511 is also
important for basement membrane zone stability, as
lama5-/- null mice contain a discontinuous lamina
densa specifically in association with hair follicles
[20,22,23]. The importance of the basement membrane
zone for epithelial downgrowth is also indicated by the
lack of invagination after LM511and LM332 inhibition
in our human xenograft model of BCC.
Previous studies of lama5-/- mice also noted the
reduced expression of SHH and GLI1 transcripts by
RNA in-situ in epithelia of E16.5 hair follicles [20]. This
indicates that LM511 may have an indirect effect on the
expression of Shh ligand, and that this effect may repre-
sent one aspect of the more extensive skin phenotype in
epithelial Itb1 mutants. Given the requirement of reci-
procal signaling during morphogenesis, we speculate
that reduced Shh signaling in the hair follicles of
lama5-/- mice may be a result of failed association of
epithelial cells with the basement membrane zone and/
or reduced expression of Shh ligand in hair follicle
epithelia, which eventually results in degeneration of
both follicle and dermal papilla. Therefore, our results
and previously published data lead us to assert a pri-
mary effect of LM511 function on epithelial cells. We
cannot yet exclude the possibility that LM511 may func-
tion via an unidentified dermal papilla receptor, but cur-
rent available data does not support this alternative.
Conclusions
￿ LM511 and LM332 are required for tumor invagi-
nation in a xenograft model of human BCC, but are
not required for Shh target gene induction or pri-
mary cilia formation.
￿ Lama5-/- mice exhibit a stage-specific defect in
hair follicle morphogenesis. Stalled hair follicles con-
tain dermal papilla with normal cell numbers, early
marker expression and cilia.
￿ Deletion of dermal Itb1 does not affect hair follicle
morphogenesis or post-natal hair cycling. Itb1-null
follicles contain dermal papilla with normal cell
numbers, early marker expression and primary cilia
￿ These results suggest that LM511 may participate
in hair follicle morphogenesis by acting on the hair
follicle epithelium, perhaps in part by facilitating




Hybridomas for mouse mAb 4c7 and BM165 to LM511
and the laminin alpha 3 chain, respectively, were pro-
vided by Dr. M. P. Marinkovich and isolated according
to previous reports [27,39]. Rabbit pAb to LM332
(pKaL), mouse mAb to Itb1 (p5D2) and rabbit anti-sera
to mouse laminin a5 were generous gifts of Dr. M. P.
Marinkovich (Stanford, CA). Additional antibodies used
were as follows: 3E1 (MAB1964), collagen VII
(MAB2500), integrin alpha-6 (MAB1378) and integrin
beta-1 (MAB1997) from Millipore (Billerica, MA); invo-
lucrin (ab53112), fibronectin (ab23750), perlecan
(ab44937), collagen I (ab34710), collagen IV (ab19808)
and tenascin C (ab6346) from Abcam (Cambridge, MA);
acetylated alpha tubulin (T6793) and control mouse IgG
(I8765) from Sigma (St. Louis, MO); adenylyl cyclase III
(sc-588) and rootletin (sc-67824) from Santa Cruz Bio-
technology (Santa Cruz, CA); human cytokeratin 10
from Dako (Denmark); keratin 14 (PRB-155P), mouse
keratin 10 (PRB-159P) and loricrin (PRB-145P) from
Covance (Princeton, NJ) and Ki67 (clone SP6) from
Neomarker (Fremont, CA).
Human skin xenografts
Xenografts were conducted as previously described [25].
For experiments receiving a single antibody (IgG, 4c7 or
BM165) animals received intraperitoneal injections car-
rying 1.0 mg of antibody every week starting in the first
week of growth. In a preliminary experiment, we deter-
mined that blocking grafts with both LM511 and
LM332 antibodies in the first week of growth resulted
in severe blistering, so we began injections in the sec-
ond week of growth. All studies involving mice were
performed in accordance with the policies of the Stan-
ford IUPAC.
Immunohistochemistry
Detection of primary cilia in 12-μm sections of paraffin
embedded tissues involved antigen retrieval with 1 mM
EDTA (pH 8.0). Blocking buffer contained 20% NHS
with 0.1% Triton X-100 and staining solution contained
5% NHS/0.1% Triton X-100. The rest of the protocol
was standard. For all other immunofluoresence (immu-
nofluoresence) on paraffin embedded tissues, 5-10 μm
sections were treated as above except that antigen
retrieval was performed with 10 mM Citrate. For immu-
nofluoresence on frozen tissues, 8 μm sections were
fixed with 4% PFA and subjected to standard staining
protocols with a blocking/staining solution consisting of
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Page 13 of 155% NHS, 0.1% Triton X-100 in PBS. Alexa Fluor (Invi-
trogen) secondary antibodies were used at 1:1000 and
Hoechst dye was used at 1:10,000. ProLong Gold Anti-
fade reagent (Invitrogen) was used for mounting.
TUNEL assays were conducted according to the TUNEL
TMR-Red Assay kit (Roche, Switzerland). Fluorescent
imaging was performed on either a Zeiss Axioskop with
Openlab software or with the Zeiss LSM 510 with Ti:
Sapphire laser for 2-photon excitation (maintained by
the Cell Sciences Imaging Facility at Stanford Univer-
sity). Confocal images and z-stacks were processed with
Zeiss LSM Image Browser and/or Volocity (Improvision)
software packages and Photoshop CS2.
DIG RNA in-situ hybridization
RNA in-situ hybridization was performed on frozen pre-
parations of xenograft tissues as previously described [40].
Mice
All mouse studies were performed in accordance with
the policies of the Stanford IUPAC. For experiments
involving WT embryonic mice, C57Bl6 mice were
mated and 12 noon on the day plugs were observed was
considered embryonic day 0.5 (E0.5). Lama5k n o c k - o u t
mice were maintained and genotyped as described pre-
v i o u s l y[ 4 1 ] .P r x 1 - C r em i c ew e r ep u r c h a s e df r o m
Jackson Labs. Itb1
flox/flox mice were obtained from Dr.
Scott Kuwada with the University of Utah and have
been previously described [22]. For the conditional
knockout of Itb1 in lateral mesenchyme, Prx1-Cre; Itb1-
flox/+ males were mated to Itb1
flox/flox or Itb1
flox/+
f e m a l e s .T h ep r e s e n c eo ft h eP r x 1 - C r et r a n s g e n ew a s
determined with primary ciliaR for Cre.
Additional material
Additional file 1: Figure S1: Blockade of LM511 and LM332 in SHH-
expressing grafts does not affect the proliferation of cells
expressing SHH ligand. Percent Ki67-positive cells of total basal or
suprabasal cells in human skin xenografts carrying either control GFP or
SHH retrovirus and treated with control IgG, 4c7 antibody against LM511
or BM165 antibody against LM332, as indicated. Quantitation
corresponds to representative images presented in Figure 1E.
Additional file 2: Figure S2: Prx1-Cre; Itb1
flox/flox mice have specific
deletion of Itb1 in dermal cells but not epithelial or endothelial
cells. Immunofluoresence for p75 (green) and Itb1 (red) in sections of
ventral skin from P1 control and conditional knockout mice at P1 (as
indicated). Zoom images in Figure 5G are extracted from these images.
Additional file 3: Figure S3: Deletion of dermal Itb1 does not
disrupt skin differentiation, BMZ components or endothelial
structures. Immunofluoresence for various markers in skin of control and
conditional knockout mice. A: Loricrin (green) and Ita6 (red) indicate
granule and corneal cell layers and basal cell layers, respectively, of
interfollicular epidermis. B: Keratin 10 (green) indicates the prickle and
granule cell layers of interfollicular epidermis. C-D: IF for tenascin C (red)
indicates a normal lack of this marker in early dermal papilla and
presence in the rest of the dermis. D: IF for fibronectin (green) indicates
a normal lack of this marker in dermal papilla and presence in ECM in
non-DP dermis. E: IF for perlecan (red) indicates normal endothelial
structures. F-G: No differences are seen in collagen I (F, green) and
collagen IV (G, green) expression in skin of control and conditional
knockouts.
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